Computational studies on glycosaminoglycan recognition of sialyl transferases.
Autor: | Sankaranarayanan NV; Department of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.; Drug Discovery and Development, Virginia Commonwealth University, Institute for Structural Biology, Virginia 23219, Richmond, USA., Sistla S; Department of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.; Drug Discovery and Development, Virginia Commonwealth University, Institute for Structural Biology, Virginia 23219, Richmond, USA., Nagarajan B; Department of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.; Drug Discovery and Development, Virginia Commonwealth University, Institute for Structural Biology, Virginia 23219, Richmond, USA., Chittum JE; Department of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.; Drug Discovery and Development, Virginia Commonwealth University, Institute for Structural Biology, Virginia 23219, Richmond, USA., Lau JTY; Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo 14263, NY, USA., Desai UR; Department of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.; Drug Discovery and Development, Virginia Commonwealth University, Institute for Structural Biology, Virginia 23219, Richmond, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Glycobiology [Glycobiology] 2023 Aug 14; Vol. 33 (7), pp. 579-590. |
DOI: | 10.1093/glycob/cwad040 |
Abstrakt: | Despite decades of research, glycosaminoglycans (GAGs) have not been known to interact with sialyl transferases (STs). Using our in-house combinatorial virtual library screening (CVLS) technology, we studied seven human isoforms, including ST6GAL1, ST6GAL2, ST3GAL1, ST3GAL3, ST3GAL4, ST3GAL5, and ST3GAL6, and predicted that GAGs, especially heparan sulfate (HS), are likely to differentially bind to STs. Exhaustive CVLS and molecular dynamics studies suggested that the common hexasaccharide sequence of HS preferentially recognized ST6GAL1 in a site overlapping the binding site of the donor substrate CMP-Sia. Interestingly, CVLS did not ascribe any special role for the rare 3-O-sulfate modification of HS in ST6GAL1 recognition. The computational predictions were tested using spectrofluorimetric studies, which confirmed preferential recognition of HS over other GAGs. A classic chain length-dependent binding of GAGs to ST6GAL1 was observed with polymeric HS displaying a tight affinity of ~65 nM. Biophysical studies also confirmed a direct competition between CMP-Sia and an HS oligosaccharide and CS polysaccharide for binding to ST6GAL1. Overall, our novel observation that GAGs bind to ST6GAL1 with high affinity and compete with the donor substrate is likely to be important because modulation of sialylation of glycan substrates on cells has considerable physiological/pathological consequences. Our work also brings forth the possibility of developing GAG-based chemical probes of ST6GAL1. (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.) |
Databáze: | MEDLINE |
Externí odkaz: |